Sarah Cannon Research Institute is a clinical research site located in Denver, Colorado, United States 80218.
Crixeo Clinical Trials Trust Score: 25/100 (FAILING). This profile has not yet been claimed by the site owner.
Sarah Cannon Research Institute has participated in 41 clinical trials with 22 currently active.
Therapeutic areas: Non-Hodgkin Lymphoma, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC).
Sponsors: Novartis Pharmaceuticals, Regeneron Pharmaceuticals, IDEAYA Biosciences.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Colorado · View every site in Denver
Trust Score: 25/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Sarah Cannon Research Institute has a Crixeo Trust Score of 25/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sarah Cannon Research Institute has 41 clinical trials on record, with 22 currently active. Their work covers Non-Hodgkin Lymphoma, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC).
Sarah Cannon Research Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.